HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shiseido Zen Aromachology Scent Boosts Alpha Wave Output, Reduces Stress

This article was originally published in The Rose Sheet

Executive Summary

Shiseido Zen revamped women's fragrance uses new aromachology techniques to explore the scent's effect on the mind and body, Shiseido Cosmetics claims. Derived from advances in Western olfactory science and Eastern Zazen philosophy, Zen "imparts a feeling of well-being and peace of mind."

You may also be interested in...



Shiseido Zen Ancillaries Expected To Generate $1 Mil. In First Year

Shiseido will introduce three Zen bath and body products in April and expects the line extensions to generate $1 mil. in first-year sales. The products are based on the same "balancing and purifying" aromachology philosophy as the original fragrance, the company said.

Shiseido Zen Ancillaries Expected To Generate $1 Mil. In First Year

Shiseido will introduce three Zen bath and body products in April and expects the line extensions to generate $1 mil. in first-year sales. The products are based on the same "balancing and purifying" aromachology philosophy as the original fragrance, the company said.

Shiseido Hair Care Test Market Kicks Off In 100 Doors

Shiseido is test marketing a hair care collection in a limited number of the company's top U.S. doors in October. Of Shiseido's 760 retail locations, the hair care line is bowing now in approximately 100 outlets, including Bloomingdale's, Macy's and Nordstrom doors.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008177

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel